脊椎用生物製剤の世界市場 2020年

• 英文タイトル：Global Spine Biologics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115189 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、脊椎用生物製剤の世界市場を調査対象にし、脊椎用生物製剤の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（骨移植片、骨移植片代替物、多血小板血漿（PRP）、BMAC（骨髄穿刺濃縮物））、用途別分析（前頸部椎間板切除術・固定術、後方腰椎椎体間固定術、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Medtronic、alphatec spine、Nuvasive、Depuy Synthes、Globus Medical、Stryker Corporation、Exactech、Orthofix International、Zimmer Biomet、K2M、Wright Medical Technology、Arthrex、X-Spine、Nutech ・企業別売上、市場シェア ・脊椎用生物製剤の地域別市場分析 ・脊椎用生物製剤の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・脊椎用生物製剤のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・脊椎用生物製剤のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・脊椎用生物製剤の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・脊椎用生物製剤の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・脊椎用生物製剤の種類別市場規模2015-2020：骨移植片、骨移植片代替物、多血小板血漿（PRP）、BMAC（骨髄穿刺濃縮物） ・脊椎用生物製剤の用途別市場規模2015-2020：前頸部椎間板切除術・固定術、後方腰椎椎体間固定術、その他 ・脊椎用生物製剤の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The Spine Biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Spine Biologics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.3%% in the forecast period of 2020 to 2025 and will expected to reach USD 2599.9 million by 2025, from USD 2278.9 million in 2019.

Market segmentation
Spine Biologics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Spine Biologics market has been segmented into:
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
BMAC (Bone Marrow Aspirate Concentrate)

By Application, Spine Biologics has been segmented into:
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Spine Biologics market presented in the report. This section sheds light on the sales growth of different regional and country-level Spine Biologics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Spine Biologics market.

The report offers in-depth assessment of the growth and other aspects of the Spine Biologics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Spine Biologics Market Share Analysis
Spine Biologics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Spine Biologics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Spine Biologics sales, revenue and market share for each player covered in this report.

The major players covered in Spine Biologics are:
Medtronic
alphatec spine
Nuvasive
Depuy Synthes
Globus Medical
Stryker Corporation
Exactech
Orthofix International
Zimmer Biomet
K2M
Wright Medical Technology
Arthrex
X-Spine
Nutech
Among other players domestic and global, Spine Biologics market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

---

1 Spine Biologics Market Overview
1.1 Product Overview and Scope of Spine Biologics
1.2 Classification of Spine Biologics by Type
1.2.1 Global Spine Biologics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Spine Biologics Revenue Market Share by Type in 2019
1.2.3 Bone Graft
1.2.4 Bone Graft Substitute
1.2.5 Platelet Rich Plasma (PRP)
1.2.6 BMAC (Bone Marrow Aspirate Concentrate)
1.3 Global Spine Biologics Market by Application
1.3.1 Overview: Global Spine Biologics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Anterior Cervical Discectomy and Fusion
1.3.3 Posterior Lumbar Interbody Fusion
1.3.4 Other
1.4 Global Spine Biologics Market by Regions
1.4.1 Global Spine Biologics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Spine Biologics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Spine Biologics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Spine Biologics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Spine Biologics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Spine Biologics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Spine Biologics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic SWOT Analysis
2.1.4 Medtronic Product and Services
2.1.5 Medtronic Spine Biologics Revenue, Gross Margin and Market Share (2018-2019)
2.2 alphatec spine
2.2.1 alphatec spine Details
2.2.2 alphatec spine Major Business
2.2.3 alphatec spine SWOT Analysis
2.2.4 alphatec spine Product and Services
2.2.5 alphatec spine Spine Biologics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Nuvasive
2.3.1 Nuvasive Details
2.3.2 Nuvasive Major Business
2.3.3 Nuvasive SWOT Analysis
2.3.4 Nuvasive Product and Services
2.3.5 Nuvasive Spine Biologics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Depuy Synthes
2.4.1 Depuy Synthes Details
2.4.2 Depuy Synthes Major Business
2.4.3 Depuy Synthes SWOT Analysis
2.4.4 Depuy Synthes Product and Services
2.4.5 Depuy Synthes Spine Biologics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Globus Medical
2.5.1 Globus Medical Details
2.5.2 Globus Medical Major Business
2.5.3 Globus Medical SWOT Analysis
2.5.4 Globus Medical Product and Services
2.5.5 Globus Medical Spine Biologics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Stryker Corporation
2.6.1 Stryker Corporation Details
2.6.2 Stryker Corporation Major Business
2.6.3 Stryker Corporation Product and Services
2.6.4 Stryker Corporation Spine Biologics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Exactech
2.7.1 Exactech Details
2.7.2 Exactech Major Business
2.7.3 Exactech Product and Services
2.7.4 Exactech Spine Biologics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Orthofix International
2.8.1 Orthofix International Details
2.8.2 Orthofix International Major Business
2.8.3 Orthofix International Product and Services
2.8.4 Orthofix International Spine Biologics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Zimmer Biomet
2.9.1 Zimmer Biomet Details
2.9.2 Zimmer Biomet Major Business
2.9.3 Zimmer Biomet Product and Services
2.9.4 Zimmer Biomet Spine Biologics Revenue, Gross Margin and Market Share (2018-2019)
2.10 K2M
2.10.1 K2M Details
2.10.2 K2M Major Business
2.10.3 K2M Product and Services
2.10.4 K2M Spine Biologics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Wright Medical Technology
2.11.1 Wright Medical Technology Details
2.11.2 Wright Medical Technology Major Business
2.11.3 Wright Medical Technology Product and Services
2.11.4 Wright Medical Technology Spine Biologics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Arthrex
2.12.1 Arthrex Details
2.12.2 Arthrex Major Business
2.12.3 Arthrex Product and Services
2.12.4 Arthrex Spine Biologics Revenue, Gross Margin and Market Share (2018-2019)
2.13 X-Spine
2.13.1 X-Spine Details
2.13.2 X-Spine Major Business
2.13.3 X-Spine Product and Services
2.13.4 X-Spine Spine Biologics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Nutech
2.14.1 Nutech Details
2.14.2 Nutech Major Business
2.14.3 Nutech Product and Services
2.14.4 Nutech Spine Biologics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Spine Biologics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Spine Biologics Players Market Share
3.2.2 Top 10 Spine Biologics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Spine Biologics Revenue and Market Share by Regions
4.2 North America Spine Biologics Revenue and Growth Rate (2015-2020)
4.3 Europe Spine Biologics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Spine Biologics Revenue and Growth Rate (2015-2020)
4.5 South America Spine Biologics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Spine Biologics Revenue and Growth Rate (2015-2020)
5 North America Spine Biologics Revenue by Countries
5.1 North America Spine Biologics Revenue by Countries (2015-2020)
5.2 USA Spine Biologics Revenue and Growth Rate (2015-2020)
5.3 Canada Spine Biologics Revenue and Growth Rate (2015-2020)
5.4 Mexico Spine Biologics Revenue and Growth Rate (2015-2020)
6 Europe Spine Biologics Revenue by Countries
6.1 Europe Spine Biologics Revenue by Countries (2015-2020)
6.2 Germany Spine Biologics Revenue and Growth Rate (2015-2020)
6.3 UK Spine Biologics Revenue and Growth Rate (2015-2020)
6.4 France Spine Biologics Revenue and Growth Rate (2015-2020)
6.5 Russia Spine Biologics Revenue and Growth Rate (2015-2020)
6.6 Italy Spine Biologics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Spine Biologics Revenue by Countries
7.1 Asia-Pacific Spine Biologics Revenue by Countries (2015-2020)
7.2 China Spine Biologics Revenue and Growth Rate (2015-2020)
7.3 Japan Spine Biologics Revenue and Growth Rate (2015-2020)
7.4 Korea Spine Biologics Revenue and Growth Rate (2015-2020)
7.5 India Spine Biologics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Spine Biologics Revenue and Growth Rate (2015-2020)
8 South America Spine Biologics Revenue by Countries
8.1 South America Spine Biologics Revenue by Countries (2015-2020)
8.2 Brazil Spine Biologics Revenue and Growth Rate (2015-2020)
8.3 Argentina Spine Biologics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Spine Biologics by Countries
9.1 Middle East & Africa Spine Biologics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Spine Biologics Revenue and Growth Rate (2015-2020)
9.3 UAE Spine Biologics Revenue and Growth Rate (2015-2020)
9.4 Egypt Spine Biologics Revenue and Growth Rate (2015-2020)
9.5 South Africa Spine Biologics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Spine Biologics Revenue and Market Share by Type (2015-2020)
10.2 Global Spine Biologics Market Forecast by Type (2019-2024)
10.3 Bone Graft Revenue Growth Rate (2015-2025)
10.4 Bone Graft Substitute Revenue Growth Rate (2015-2025)
10.5 Platelet Rich Plasma (PRP) Revenue Growth Rate (2015-2025)
10.6 BMAC (Bone Marrow Aspirate Concentrate) Revenue Growth Rate (2015-2025)
11 Global Spine Biologics Market Segment by Application
11.1 Global Spine Biologics Revenue Market Share by Application (2015-2020)
11.2 Spine Biologics Market Forecast by Application (2019-2024)
11.3 Anterior Cervical Discectomy and Fusion Revenue Growth (2015-2020)
11.4 Posterior Lumbar Interbody Fusion Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Spine Biologics Market Size Forecast (2021-2025)
12.1 Global Spine Biologics Market Size Forecast (2021-2025)
12.2 Global Spine Biologics Market Forecast by Regions (2021-2025)
12.3 North America Spine Biologics Revenue Market Forecast (2021-2025)
12.4 Europe Spine Biologics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Spine Biologics Revenue Market Forecast (2021-2025)
12.6 South America Spine Biologics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Spine Biologics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Spine Biologics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Spine Biologics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Spine Biologics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Spine Biologics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Spine Biologics Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Medtronic Corporate Information, Location and Competitors
Table 7. Medtronic Spine Biologics Major Business
Table 8. Medtronic Spine Biologics Total Revenue (USD Million) (2017-2018)
Table 9. Medtronic SWOT Analysis
Table 10. Medtronic Spine Biologics Product and Solutions
Table 11. Medtronic Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. alphatec spine Corporate Information, Location and Competitors
Table 13. alphatec spine Spine Biologics Major Business
Table 14. alphatec spine Spine Biologics Total Revenue (USD Million) (2018-2019)
Table 15. alphatec spine SWOT Analysis
Table 16. alphatec spine Spine Biologics Product and Solutions
Table 17. alphatec spine Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Nuvasive Corporate Information, Location and Competitors
Table 19. Nuvasive Spine Biologics Major Business
Table 20. Nuvasive Spine Biologics Total Revenue (USD Million) (2017-2018)
Table 21. Nuvasive SWOT Analysis
Table 22. Nuvasive Spine Biologics Product and Solutions
Table 23. Nuvasive Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Depuy Synthes Corporate Information, Location and Competitors
Table 25. Depuy Synthes Spine Biologics Major Business
Table 26. Depuy Synthes Spine Biologics Total Revenue (USD Million) (2017-2018)
Table 27. Depuy Synthes SWOT Analysis
Table 28. Depuy Synthes Spine Biologics Product and Solutions
Table 29. Depuy Synthes Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Globus Medical Corporate Information, Location and Competitors
Table 31. Globus Medical Spine Biologics Major Business
Table 32. Globus Medical Spine Biologics Total Revenue (USD Million) (2017-2018)
Table 33. Globus Medical SWOT Analysis
Table 34. Globus Medical Spine Biologics Product and Solutions
Table 35. Globus Medical Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Stryker Corporation Corporate Information, Location and Competitors
Table 37. Stryker Corporation Spine Biologics Major Business
Table 38. Stryker Corporation Spine Biologics Total Revenue (USD Million) (2017-2018)
Table 39. Stryker Corporation SWOT Analysis
Table 40. Stryker Corporation Spine Biologics Product and Solutions
Table 41. Stryker Corporation Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Exactech Corporate Information, Location and Competitors
Table 43. Exactech Spine Biologics Major Business
Table 44. Exactech Spine Biologics Total Revenue (USD Million) (2017-2018)
Table 45. Exactech SWOT Analysis
Table 46. Exactech Spine Biologics Product and Solutions
Table 47. Exactech Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Orthofix International Corporate Information, Location and Competitors
Table 49. Orthofix International Spine Biologics Major Business
Table 50. Orthofix International Spine Biologics Total Revenue (USD Million) (2017-2018)
Table 51. Orthofix International SWOT Analysis
Table 52. Orthofix International Spine Biologics Product and Solutions
Table 53. Orthofix International Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Zimmer Biomet Corporate Information, Location and Competitors
Table 55. Zimmer Biomet Spine Biologics Major Business
Table 56. Zimmer Biomet Spine Biologics Total Revenue (USD Million) (2017-2018)
Table 57. Zimmer Biomet SWOT Analysis
Table 58. Zimmer Biomet Spine Biologics Product and Solutions
Table 59. Zimmer Biomet Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. K2M Corporate Information, Location and Competitors
Table 61. K2M Spine Biologics Major Business
Table 62. K2M Spine Biologics Total Revenue (USD Million) (2017-2018)
Table 63. K2M SWOT Analysis
Table 64. K2M Spine Biologics Product and Solutions
Table 65. K2M Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Wright Medical Technology Corporate Information, Location and Competitors
Table 67. Wright Medical Technology Spine Biologics Major Business
Table 68. Wright Medical Technology Spine Biologics Total Revenue (USD Million) (2017-2018)
Table 69. Wright Medical Technology SWOT Analysis
Table 70. Wright Medical Technology Spine Biologics Product and Solutions
Table 71. Wright Medical Technology Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Arthrex Corporate Information, Location and Competitors
Table 73. Arthrex Spine Biologics Major Business
Table 74. Arthrex Spine Biologics Total Revenue (USD Million) (2017-2018)
Table 75. Arthrex SWOT Analysis
Table 76. Arthrex Spine Biologics Product and Solutions
Table 77. Arthrex Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. X-Spine Corporate Information, Location and Competitors
Table 79. X-Spine Spine Biologics Major Business
Table 80. X-Spine Spine Biologics Total Revenue (USD Million) (2017-2018)
Table 81. X-Spine SWOT Analysis
Table 82. X-Spine Spine Biologics Product and Solutions
Table 83. X-Spine Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Nutech Corporate Information, Location and Competitors
Table 85. Nutech Spine Biologics Major Business
Table 86. Nutech Spine Biologics Total Revenue (USD Million) (2017-2018)
Table 87. Nutech SWOT Analysis
Table 88. Nutech Spine Biologics Product and Solutions
Table 89. Nutech Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Global Spine Biologics Revenue (Million USD) by Players (2015-2020)
Table 91. Global Spine Biologics Revenue Share by Players (2015-2020)
Table 92. Global Spine Biologics Revenue (Million USD) by Regions (2015-2020)
Table 93. Global Spine Biologics Revenue Market Share by Regions (2015-2020)
Table 94. North America Spine Biologics Revenue by Countries (2015-2020)
Table 95. North America Spine Biologics Revenue Market Share by Countries (2015-2020)
Table 96. Europe Spine Biologics Revenue (Million USD) by Countries (2015-2020)
Table 97. Asia-Pacific Spine Biologics Revenue (Million USD) by Countries (2015-2020)
Table 98. South America Spine Biologics Revenue by Countries (2015-2020)
Table 99. South America Spine Biologics Revenue Market Share by Countries (2015-2020)
Table 100. Middle East and Africa Spine Biologics Revenue (Million USD) by Countries (2015-2020)
Table 101. Middle East and Africa Spine Biologics Revenue Market Share by Countries (2015-2020)
Table 102. Global Spine Biologics Revenue (Million USD) by Type (2015-2020)
Table 103. Global Spine Biologics Revenue Share by Type (2015-2020)
Table 104. Global Spine Biologics Revenue Forecast by Type (2021-2025)
Table 105. Global Spine Biologics Revenue by Application (2015-2020)
Table 106. Global Spine Biologics Revenue Share by Application (2015-2020)
Table 107. Global Spine Biologics Revenue Forecast by Application (2021-2025)
Table 108. Global Spine Biologics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Spine Biologics Picture
Figure 2. Global Spine Biologics Revenue Market Share by Type in 2019
Figure 3. Bone Graft Picture
Figure 4. Bone Graft Substitute Picture
Figure 5. Platelet Rich Plasma (PRP) Picture
Figure 6. BMAC (Bone Marrow Aspirate Concentrate) Picture
Figure 7. Spine Biologics Revenue Market Share by Application in 2019
Figure 8. Anterior Cervical Discectomy and Fusion Picture
Figure 9. Posterior Lumbar Interbody Fusion Picture
Figure 10. Other Picture
Figure 11. Global Spine Biologics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Spine Biologics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Spine Biologics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Spine Biologics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Spine Biologics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Spine Biologics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Spine Biologics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Spine Biologics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Spine Biologics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Spine Biologics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Spine Biologics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Spine Biologics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Spine Biologics Revenue Market Share by Regions in 2018
Figure 25. North America Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 28. South America Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 30. North America Spine Biologics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Spine Biologics Revenue Market Share by Countries in 2019
Figure 32. USA Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Spine Biologics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Spine Biologics Revenue Market Share by Countries in 2019
Figure 37. Germany Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 38. UK Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 39. France Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Spine Biologics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Spine Biologics Revenue Market Share by Countries in 2019
Figure 44. China Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 47. India Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 49. South America Spine Biologics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Spine Biologics Revenue Market Share by Countries in 2019
Figure 51. Brazil Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Spine Biologics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Spine Biologics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Spine Biologics Revenue and Growth Rate (2015-2020)
Figure 59. Global Spine Biologics Revenue Share by Type (2015-2020)
Figure 60. Global Spine Biologics Revenue Share by Type in 2019
Figure 61. Global Spine Biologics Market Share Forecast by Type (2021-2025)
Figure 62. Global Bone Graft Revenue Growth Rate (2015-2020)
Figure 63. Global Bone Graft Substitute Revenue Growth Rate (2015-2020)
Figure 64. Global Platelet Rich Plasma (PRP) Revenue Growth Rate (2015-2020)
Figure 65. Global BMAC (Bone Marrow Aspirate Concentrate) Revenue Growth Rate (2015-2020)
Figure 66. Global Spine Biologics Revenue Share by Application (2015-2020)
Figure 67. Global Spine Biologics Revenue Share by Application in 2019
Figure 68. Global Spine Biologics Market Share Forecast by Application (2021-2025)
Figure 69. Global Anterior Cervical Discectomy and Fusion Revenue Growth Rate (2015-2020)
Figure 70. Global Posterior Lumbar Interbody Fusion Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Spine Biologics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Spine Biologics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Spine Biologics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Spine Biologics Revenue Market Forecast (2021-2025)
Figure 76. Europe Spine Biologics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Spine Biologics Revenue Market Forecast (2021-2025)
Figure 78. South America Spine Biologics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Spine Biologics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---